- Current state of the global economy: examines prevailing economic conditions globally and across various regions - Company and industry growth outlook: provides industry executives’ expectations towards the growth prospects of their company and the industry over the next six months - Change in customer confidence: analyzes pharmaceutical industry executives’ opinion about the change in customer confidence during H2 2016 - Supplier prices projection: determines expected change in supplier prices across various categories and their impact on business confidence - Change in staff headcount and sales performance: tracks expected change in staff headcount and sales for H2 2016 among industry executives globally - Significant investment activities: highlights various areas in which industry executives intend to invest over the next six months - Business concerns: provides information about potential business concerns indicated by survey respondents for H1 2016 - Key priorities: identifies the top priorities of industry executives operating in various regions
- Economic environment is more favorable in Eastern Europe and Australasia in H2 2016 as compared to H1 2016 - The majority of respondents communicated optimism about company and industry growth prospects for the next six months - Globally, supplier prices of ingredients are anticipated to increase by 2.5% over the next six months - Survey results indicate highest increase in spending on new product development in H2 2016 as compared to H1 2016 - Respondents with business operations in Asia-Pacific are more concerned about the performance of developing economies in H2 2016 as compared to H1 2016 - Organizations intend to focus on new product development and improving operational efficiency during the next six months Request a sample copy at http://www.reportsweb.com/inquiry&RW00020666/sample
Reason to Buy - Helps organizations to make effective business strategy decisions by knowing the prevailing business conditions and sentiment within the pharmaceutical industry - Organizations will be supported in business expansion decisions by providing information about projected change in sales performance and supplier prices - Helps to improve operational efficiency of the organization by knowing about key priorities and the main concerns of pharmaceutical industry executives - Helps to alter investment allocation by understanding key focus areas highlighted by survey respondents during H2 2016
Economic state, growth prospects and consumer confidence - Existing economic environment - Industry and company growth outlook - Expected change in consumer confidence
Supplier prices, staff headcount and sales performance - Supplier prices expectations - Anticipated change in staff head count and sales projections - Anticipated change in spend on key activities
Business concerns and organizational priorities - Level of concerns and expected impact - Significance of potential business priorities
Appendix
Key Companies profiles
Pfizer Inc. Sanofi S.A. Novartis International AG Mylan N.V. PeptiDream Genentech